To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(69 sites)

United States

University of California, San Francisco Fresno, Clovis, California

University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600, Santa Monica, California

University of Colorado School of Medicine, Aurora, Colorado

Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute, Pembroke Pines, Florida

Norton Cancer Institute, Louisville, Kentucky